Position in BMY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$875,708
-$57,270 QoQ
Shares Held
15,198
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,246
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GARRISON POINT ADVISORS, LLC holds $11,648,529 across 8 Drug Manufacturers - General names. BMY ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,613 | $4,219,203 | |
| 2 | AMGN |
Amgen Inc
|
5,460 | $1,977,175 | |
| 3 | NVO |
Novo Nordisk A S
|
33,268 | $1,594,867 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,116 | $1,556,906 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
15,198 | $875,708 | |
| 6 | ABBV |
AbbVie Inc.
|
3,016 | $758,946 | |
| 7 | LLY |
ELI LILLY & Co
|
345 | $413,803 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,994 | $251,921 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $875,708 | 15,198 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $932,978 | 15,383 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $830,082 | 15,389 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $665,270 | 14,751 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $648,337 | 14,006 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,008,225 | 16,531 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $923,681 | 16,331 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $844,965 | 16,331 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $700,444 | 16,866 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $947,398 | 17,470 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $916,909 | 17,870 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,060,739 | 18,276 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,181,796 | 18,480 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,289,859 | 18,610 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,340,860 | 18,636 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,324,833 | 18,636 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,434,972 | 18,636 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,353,684 | 18,536 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,155,719 | 18,536 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,096,775 | 18,536 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,230,557 | 18,416 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,155,910 | 18,310 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,140,111 | 18,380 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,078,889 | 17,895 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,058,106 | 17,995 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,029,685 | 18,473 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||